United Kingdom: Food and Drugs Law

GLP-1 weight-loss medications like Wegovy, Mounjaro and Ozempic have seen explosive growth in both NHS and private healthcare settings, with over four million prescriptions dispensed in 2025/26 alone. As millions more UK adults plan to start treatment and online providers proliferate, healthcare professionals face mounting exposure to clinical negligence claims arising from inadequate assessment, consent processes, and patient monitoring. What are the key risk factors driving potential litigation, and how c

Following a commitment in the King's Speech in 2024, the government consulted about banning the sale of high-caffeine drinks to under 16s in England, receiving 1,095 responses. It has now confirmed that it will ban the sale of high-caffeine energy drinks to under-16s in England from April 2027.

The European Union has reached a political agreement to significantly extend compliance deadlines for high-risk AI systems under the AI Act, with businesses now having until December 2027 or August 2028 depending on their category. The revised framework introduces separate timelines for different types of high-risk AI applications, narrows certain definitions, and provides regulatory relief for small and medium-sized companies while adding new prohibitions on non-consensual intimate content generation.